These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 14644822)

  • 1. How low can you get?
    Brincat M; Baron YM; Galea R
    Ann N Y Acad Sci; 2003 Nov; 997():158-62. PubMed ID: 14644822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A; De Leo V
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethinyl estradiol and 17β-estradiol in combined oral contraceptives: pharmacokinetics, pharmacodynamics and risk assessment.
    Stanczyk FZ; Archer DF; Bhavnani BR
    Contraception; 2013 Jun; 87(6):706-27. PubMed ID: 23375353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An open assessment of a new low dose oestrogen combined oral contraceptive.
    Hughes I
    J Int Med Res; 1978; 6(1):41-5. PubMed ID: 627304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial function across an oral contraceptive cycle in women using levonorgestrel and ethinyl estradiol.
    Torgrimson BN; Meendering JR; Kaplan PF; Minson CT
    Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2874-80. PubMed ID: 17277029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of a 21/7-active combined oral contraceptive with continuous low-dose ethinyl estradiol.
    Kroll R; Ackerman R; Feldman R; Howard B; Weiss H; Hsieh J; Ricciotti N
    Contraception; 2016 Mar; 93(3):249-56. PubMed ID: 26499407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new contraceptive pill containing 17β-estradiol and nomegestrol acetate.
    Christin-Maitre S; Laroche E; Bricaire L
    Womens Health (Lond); 2013 Jan; 9(1):13-23. PubMed ID: 23241152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a continuous regimen of levonorgestrel/ethinyl estradiol: phase 3 study results.
    Archer DF; Jensen JT; Johnson JV; Borisute H; Grubb GS; Constantine GD
    Contraception; 2006 Dec; 74(6):439-45. PubMed ID: 17157099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Types of progestogens in combined oral contraception: effectiveness and side-effects.
    Lawrie TA; Helmerhorst FM; Maitra NK; Kulier R; Bloemenkamp K; Gülmezoglu AM
    Cochrane Database Syst Rev; 2011 May; (5):CD004861. PubMed ID: 21563141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five-year, multicenter study of a triphasic, low-dose, combination oral contraceptive.
    Woutersz TB; Korba VD
    Int J Fertil; 1988; 33(6):406-10. PubMed ID: 2906915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical study of the low dose oral contraceptive novynette].
    Uchikova E; Milchev N
    Akush Ginekol (Sofiia); 2003; 42(4):15-6. PubMed ID: 14577362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hormonal profile in women using combined monophasic oral contraceptive pills varies across the pill cycle: a temporal analysis of serum endogenous and exogenous hormones using liquid chromatography with tandem mass spectroscopy.
    Rodriguez LA; Casey E; Crossley E; Williams N; Dhaher YY
    Am J Physiol Endocrinol Metab; 2024 Jul; 327(1):E121-E133. PubMed ID: 38775726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An open-label, multicenter, noncomparative safety and efficacy study of Mircette, a low-dose estrogen-progestin oral contraceptive. The Mircette Study Group.
    Am J Obstet Gynecol; 1998 Jul; 179(1):S2-8. PubMed ID: 9704812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phasic approach to oral contraceptives.
    Hale RW
    Am J Obstet Gynecol; 1987 Oct; 157(4 Pt 2):1052-8. PubMed ID: 3118718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined hormonal contraception.
    Calderoni ME; Coupey SM
    Adolesc Med Clin; 2005 Oct; 16(3):517-37. PubMed ID: 16183537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective multicentre study comparing levonorgestrel implants with a combined contraceptive pill: final results.
    Kirkman RJ; Bromham DR; O'Connor TP; Sahota JE
    Br J Fam Plann; 1999 Jul; 25(2):36-40. PubMed ID: 10454652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Menstrual regulation by sequential hormone therapy.
    Beaton JH
    West J Surg Obstet Gynecol; 1964; 72():160-3. PubMed ID: 12332438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of an ascending-dose, extended-regimen levonorgestrel/ethinyl estradiol combined oral contraceptive.
    Portman DJ; Kaunitz AM; Howard B; Weiss H; Hsieh J; Ricciotti N
    Contraception; 2014 Apr; 89(4):299-306. PubMed ID: 24576794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of cycle control, side effects and client's satisfaction of a low dose combined contraceptive containing ethinylestradiol/drospirenone (24/4 regimen).
    Chaiyasit N; Taneepanichskul S
    J Med Assoc Thai; 2010 May; 93(5):517-22. PubMed ID: 20524436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy and safety of drospirenone-ethinylestradiol on contraception in healthy Chinese women: a multicenter randomized controlled trial].
    Fan GS; Bian ML; Cheng LN; Cao XM; Huang ZR; Han ZY; Jing XP; Li J; Wu SY; Xiong CL; Xiong ZA; Yue TF
    Zhonghua Fu Chan Ke Za Zhi; 2009 Jan; 44(1):38-44. PubMed ID: 19563061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.